Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Biofrontera AG
  6. News
  7. Summary
    B8F   DE0006046113

BIOFRONTERA AG

(B8F)
  Report
Delayed Xetra  -  11:36 2022-09-30 am EDT
1.465 EUR   +2.45%
09/06Biofrontera Obtains Notice of Allowance for US Patent Related to Nanoemulsion Technology
MT
08/25Biofrontera AG Appoints Prof. Dr. Karin Lergenmüller to the Supervisory Board
CI
08/19Biofrontera AG Announces Appointment of Pilar de la Huerta Martinez as New Chief Financial Officer
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

PTA-DD: Biofrontera AG: Managers' transactions announcement according to article 19 MAR

07/20/2022 | 11:44am EDT
Director's Dealings
PTA-DD: Biofrontera AG: Managers' transactions announcement according to article 19 MAR

07/20/2022 deDDMar

Managers' transactions announcement according to article 19 MAR

Leverkusen, Germany (pta028/20.07.2022/17:30) - Announcement

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Deutsche Balaton Aktiengesellschaft
2 Reason for the notification
a) Position/status Person closely associated
Wilhelm K. T. Zours
Member of the administrative or supervisory body
b) Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Biofrontera AG
b) LEI 391200D6GFSVFGFQTL13
4 Details of the transaction(s)
a) Description of the financial instrument, type of instrument Share
Identification code DE0006046113
b) Nature of the transaction Purchase
c) Price(s) Volume(s)
1.175 EUR 1,175.00 EUR
1.175 EUR 1,175.00 EUR
1.175 EUR 1,175.00 EUR
d) Aggregated price Aggregated volume
1.175 EUR 3,525.00 EUR
e) Date of the transaction 18.07.2022 UTC+2
f) Place of the transaction Outside a trading venue

(end)

emitter: Biofrontera AG
address: Hemmelrather Weg 201, 51377 Leverkusen
country: Germany
contact person: Investor Relations
phone: +49 (0) 214 87 63 20
e-mail: ir@biofrontera.com
website: www.biofrontera.com

ISIN(s): DE0006046113 (share)
stock exchanges: regulated market in Frankfurt, Dusseldorf; free market in Stuttgart, free market in Munich; open market in Berlin, Tradegate
other stock exchanges: US OTC

[ source: https://www.pressetext.com/news/20220720028 ]

Directors' Dealings archive
2021
PTA-DD: Biofrontera AG: Managers' transactions announcement according to article 19 MAR

07/20/2022 deDDMar

Managers' transactions announcement according to article 19 MAR

Leverkusen, Germany (pta028/20.07.2022/17:30) - Announcement

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Deutsche Balaton Aktiengesellschaft
2 Reason for the notification
a) Position/status Person closely associated
Wilhelm K. T. Zours
Member of the administrative or supervisory body
b) Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Biofrontera AG
b) LEI 391200D6GFSVFGFQTL13
4 Details of the transaction(s)
a) Description of the financial instrument, type of instrument Share
Identification code DE0006046113
b) Nature of the transaction Purchase
c) Price(s) Volume(s)
1.175 EUR 1,175.00 EUR
1.175 EUR 1,175.00 EUR
1.175 EUR 1,175.00 EUR
d) Aggregated price Aggregated volume
1.175 EUR 3,525.00 EUR
e) Date of the transaction 18.07.2022 UTC+2
f) Place of the transaction Outside a trading venue

(end)

emitter: Biofrontera AG
address: Hemmelrather Weg 201, 51377 Leverkusen
country: Germany
contact person: Investor Relations
phone: +49 (0) 214 87 63 20
e-mail: ir@biofrontera.com
website: www.biofrontera.com

ISIN(s): DE0006046113 (share)
stock exchanges: regulated market in Frankfurt, Dusseldorf; free market in Stuttgart, free market in Munich; open market in Berlin, Tradegate
other stock exchanges: US OTC

[ source: https://www.pressetext.com/news/20220720028 ]

Directors' dealings PDF archive
2020 (Text messages)
PTA-DD: Biofrontera AG: Managers' transactions announcement according to article 19 MAR

07/20/2022 deDDMar

Managers' transactions announcement according to article 19 MAR

Leverkusen, Germany (pta028/20.07.2022/17:30) - Announcement

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Deutsche Balaton Aktiengesellschaft
2 Reason for the notification
a) Position/status Person closely associated
Wilhelm K. T. Zours
Member of the administrative or supervisory body
b) Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Biofrontera AG
b) LEI 391200D6GFSVFGFQTL13
4 Details of the transaction(s)
a) Description of the financial instrument, type of instrument Share
Identification code DE0006046113
b) Nature of the transaction Purchase
c) Price(s) Volume(s)
1.175 EUR 1,175.00 EUR
1.175 EUR 1,175.00 EUR
1.175 EUR 1,175.00 EUR
d) Aggregated price Aggregated volume
1.175 EUR 3,525.00 EUR
e) Date of the transaction 18.07.2022 UTC+2
f) Place of the transaction Outside a trading venue

(end)

emitter: Biofrontera AG
address: Hemmelrather Weg 201, 51377 Leverkusen
country: Germany
contact person: Investor Relations
phone: +49 (0) 214 87 63 20
e-mail: ir@biofrontera.com
website: www.biofrontera.com

ISIN(s): DE0006046113 (share)
stock exchanges: regulated market in Frankfurt, Dusseldorf; free market in Stuttgart, free market in Munich; open market in Berlin, Tradegate
other stock exchanges: US OTC

[ source: https://www.pressetext.com/news/20220720028 ]

Disclaimer

Biofrontera AG published this content on 20 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 July 2022 15:43:07 UTC.


© Publicnow 2022
All news about BIOFRONTERA AG
09/06Biofrontera Obtains Notice of Allowance for US Patent Related to Nanoemulsion Technolog..
MT
08/25Biofrontera AG Appoints Prof. Dr. Karin Lergenmüller to the Supervisory Board
CI
08/19Biofrontera AG Announces Appointment of Pilar de la Huerta Martinez as New Chief Financ..
CI
08/19Pta-news : Biofrontera AG: Biofrontera extends appointment of Management Board member Paul..
PU
08/19Biofrontera AG Extends Appointment of Management Board Member Paul Böckmann
CI
08/18Pta-news : Biofrontera AG: Biofrontera reports financial results for the six months ended ..
PU
08/18Biofrontera AG Provides Earnings Guidance for the Full Year of 2022
CI
08/17Pta-dd : Biofrontera AG: Managers' transactions announcement according to article 19 MAR
PU
08/12Earnings Flash (BFRI) BIOFRONTERA Posts Q2 Revenue $4.5M, vs. Street Est of $4.54M
MT
08/10Pta-news : Biofrontera AG: The request to convene an extraordinary shareholders' meeting b..
PU
More news
Financials
Sales 2022 26,2 M 25,7 M 25,7 M
Net income 2022 -38,1 M -37,4 M -37,4 M
Net Debt 2022 - - -
P/E ratio 2022 -2,44x
Yield 2022 -
Capitalization 83,1 M 81,5 M 81,5 M
Capi. / Sales 2022 3,17x
Capi. / Sales 2023 2,72x
Nbr of Employees 98
Free-Float 43,4%
Chart BIOFRONTERA AG
Duration : Period :
Biofrontera AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIOFRONTERA AG
Short TermMid-TermLong Term
TrendsBullishBullishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 1,47 €
Average target price 2,80 €
Spread / Average Target 91,1%
EPS Revisions
Managers and Directors
Maria del Pilar de la Huerta Martinez Chief Financial Officer
Wilhelm Konrad Zours Chairman-Supervisory Board
Heikki Lanckriet Member-Supervisory Board
Helge Lubenow Member-Supervisory Board
Karlheinz Schmelig Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
BIOFRONTERA AG-1.01%81
CSL LIMITED-1.96%88 546
SAMSUNG BIOLOGICS CO.,LTD.-10.63%39 998
BIOGEN INC.11.29%38 745
WUXI BIOLOGICS (CAYMAN) INC.-48.78%25 758
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.-30.63%19 438